World News: 13:28 GMT Saturday 10th November 2018. [Schall Law via Globe Newswire via SPi World News]
LOS ANGELES, Nov. 10, 2018 (GLOBE NEWSWIRE) -- , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cocrystal Pharma, Inc. (“Cocrystal” or “the Company”) (NASDAQ: ) and of Cocrystal’s predecessor, BioZone Pharmaceuticals, Inc. (BioZone) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's shares between September 23, 2013 and September 7, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before November 19, 2018.
If you are a shareholder who suffered a loss, .
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at , or by email at .
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. The SEC filed a lawsuit on September 7, 2018, against former officers of Cocrystal’s predecessor company, BioZone, amongst other individuals and corporations. The SEC alleges that the defendants were participating in “highly profitable ‘pump-and-dump’ schemes . . . from 2013 through 2018” involving three public companies, including BioZone, that, “while enriching Defendants by millions of dollars, left retail investors holding virtually worthless shares.” Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth, investors suffered losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The Schall Law Firm Brian Schall, Esq., Sherin Mahdavian, Esq., 310-301-3335
The Schall Law Firm
Globe Newswire: 13:28 GMT Saturday 10th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.